VIDEO: Accelerating the Drug Discovery Timeline
Improving lives has always been the ultimate goal for PerkinElmer’s Life Sciences—and we do this by delivering innovative, advanced solutions to those developing treatments and drugs.
Drug development can take years from the beginnings of basic research into understanding disease pathophysiology to the commercialization of a new medicine, and the right tools can make all the difference.
When the pace of drug discovery for COVID-19 needed to be accelerated, a team of scientists at the National Institutes of Health turned to a PerkinElmer solution—AlphaLISA®. By reaching for the right tool, those researchers were able to pinpoint 25 known drugs that could be used to treat those infected with the SARS-CoV-2 virus.
That assay is one of the hundreds of reagents, instruments, and devices PerkinElmer has developed to boost drug discovery and development process.
Learn more about the portfolio of solutions that can make all the difference:
To keep up to date on all the latest PerkinElmer news, subscribe to our blog at the top of the page.